Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IPI-3063 是一种选择性 PI3K p110δ抑制剂,其 IC50=2.5±1.2 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 639 | 现货 | ||
2 mg | ¥ 937 | 现货 | ||
5 mg | ¥ 1,670 | 现货 | ||
10 mg | ¥ 2,730 | 现货 | ||
25 mg | ¥ 4,480 | 现货 | ||
50 mg | ¥ 6,280 | 现货 | ||
100 mg | ¥ 8,490 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,770 | 现货 |
产品描述 | IPI-3063 is an effective and selective inhibitor of PI3K p110δ (IC50: 2.5 ± 1.2 nM). |
靶点活性 | p110α:1170 nM, p110γ:2187 nM, p110δ:2.5 nM, p110β:1508 nM |
体外活性 | IPI-3063 is a p110δ selective compound with an IC50=0.1?nM in p110δ-specific cell-based assays and cellular IC50 values for the other class I PI3K isoforms are at least 1,000-fold higher (IC50=1901±1318 nM for p110α, IC50=102.8±35.7 nM for p110β, IC50=418.8±117.2 nM for p110γ). IPI-3063 is very effective in reducing p-AKT (significant effect at 1?nM) and it also decreases p-ERK1/2 with a significant effect at 10?nM. IPI-3063 is very effective, achieving a significant decrease in B cell survival when present at 10?nM and it also inhibits p110α, p110β, and p110γ (IC50s: 1171±533 nM, 1508±624 nM, and 2187±1529 nM, respectively). IPI-3063 effectively decreases mouse B cell proliferation, survival, and plasmablast differentiation while increasing antibody class switching to IgG1. |
分子量 | 455.51 |
分子式 | C25H25N7O2 |
CAS No. | 1425043-73-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.33 mg/mL (182.94 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.1953 mL | 10.9767 mL | 21.9534 mL | 54.8835 mL |
5 mM | 0.4391 mL | 2.1953 mL | 4.3907 mL | 10.9767 mL | |
10 mM | 0.2195 mL | 1.0977 mL | 2.1953 mL | 5.4884 mL | |
20 mM | 0.1098 mL | 0.5488 mL | 1.0977 mL | 2.7442 mL | |
50 mM | 0.0439 mL | 0.2195 mL | 0.4391 mL | 1.0977 mL | |
100 mM | 0.022 mL | 0.1098 mL | 0.2195 mL | 0.5488 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IPI-3063 1425043-73-7 PI3K/Akt/mTOR signaling PI3K Inhibitor Phosphoinositide 3-kinase inhibit IPI3063 IPI 3063 inhibitor